Publication:
CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY

dc.contributor.authorGÜRSU M.
dc.contributor.authorÖZTÜRK S.
dc.contributor.authorARICI M.
dc.contributor.authorSahin I.
dc.contributor.authorGoekcay Bek S.
dc.contributor.authorYilmaz M.
dc.contributor.authorKoyuncu S.
dc.contributor.authorKarahisar Sirali S.
dc.contributor.authorUral Z.
dc.contributor.authorDursun B.
dc.contributor.authoret al.
dc.contributor.institutionauthorGÜRSU, MELTEM
dc.date.accessioned2023-01-08T22:40:59Z
dc.date.available2023-01-08T22:40:59Z
dc.date.issued2022-11-01
dc.description.abstractBackground: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome.Methods: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were recorded.Results: We enrolled 142 COVID-19 patients (median age:52 years). 58.2% of patients had mild disease at diagnosis. Lung involvement was detected in 60.8% of patients. 83 (58.4%) patients were hospitalized, 31 (21.8%) patients were admitted to intensive care unit and 24 needed mechanical ventilation. 15 (10.5%) patients were switched to hemodialysis and hemodiafiltration was performed for four (2.8%) patients. Persisting pulmonary symptoms (n=27), lower respiratory system infection (n=12), rehospitalization for any reason (n=24), malnutrition (n=6), hypervolemia (n=13), peritonitis (n=7), ultrafiltration failure (n=7) and in PD modality change (n=8) were reported in survivors. 26 patients (18.31%) died in the first month of diagnosis. The non-survivor group was older, comorbidities were more prevalent. Fever, dyspnea, cough, serious-vital disease at presentation, bilateral pulmonary involvement, and pleural effusion were more frequent among non-survivors. Age (OR:1.102; 95%CI: 1.032-1.117; p: 0.004), moderate-severe clinical disease at presentation (OR:26.825; 95%CI: 4.578-157.172; p<0.001) and baseline CRP (OR:1.008; 95%CI; 1.000-1.016; p:0.040) were associated with first-month mortality in multivariate analysis.Conclusions: Early mortality rate and medical complications are quite high in PD patients with COVID-19. Age, clinical severity of COVID-19, and baseline CRP level are the independent parameters associated with mortality.
dc.identifier.citationGÜRSU M., ÖZTÜRK S., ARICI M., Sahin I., Goekcay Bek S., Yilmaz M., Koyuncu S., Karahisar Sirali S., Ural Z., Dursun B., et al., "CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY", KIDNEY & BLOOD PRESSURE RESEARCH, cilt.47, sa.10, ss.605-615, 2022
dc.identifier.doi10.1159/000526909
dc.identifier.endpage615
dc.identifier.issn1420-4096
dc.identifier.issue10
dc.identifier.startpage605
dc.identifier.urihttps://avesis.bezmialem.edu.tr/api/publication/4d42f091-19a5-43ec-95dd-4a3f1a5297b9/file
dc.identifier.urihttps://hdl.handle.net/20.500.12645/34806
dc.identifier.volume47
dc.relation.ispartofKIDNEY & BLOOD PRESSURE RESEARCH
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectFizyoloji
dc.subjectTemel Bilimler
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectInternal Diseases
dc.subjectNephrology
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectFundamental Medical Sciences
dc.subjectBiochemistry
dc.subjectHuman Physiology
dc.subjectNatural Sciences
dc.subjectFİZYOLOJİ
dc.subjectBiyoloji ve Biyokimya
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectPERİFERİK DAMAR HASTALIKLARI
dc.subjectPHYSIOLOGY
dc.subjectBIOLOGY & BIOCHEMISTRY
dc.subjectLife Sciences (LIFE)
dc.subjectUROLOGY & NEPHROLOGY
dc.subjectCLINICAL MEDICINE
dc.subjectClinical Medicine (MED)
dc.subjectPERIPHERAL VASCULAR DISEASE
dc.subjectÜroloji
dc.subjectFizyoloji (tıbbi)
dc.subjectBiyokimya (tıbbi)
dc.subjectUrology
dc.subjectPhysiology (medical)
dc.subjectBiochemistry (medical)
dc.subjectPhysiology
dc.titleCHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY
dc.typeArticle
dspace.entity.typePublication
local.avesis.id4d42f091-19a5-43ec-95dd-4a3f1a5297b9
local.publication.goal02 - Açlığa Son
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
relation.isAuthorOfPublicationa6446eac-0ccd-4457-9227-3fc72dec68d1
relation.isAuthorOfPublication.latestForDiscoverya6446eac-0ccd-4457-9227-3fc72dec68d1
relation.isGoalOfPublication5246edf8-60d4-4a7b-9a27-c73e4a636141
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery5246edf8-60d4-4a7b-9a27-c73e4a636141

Files